Genelux (GNLX) Earnings Date & Reports

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GNLX is expected to report earnings to fall 12.00% to -21 cents per share on May 08

Q1'25

Est.

$-0.22

Q4'24

Est.

$-0.25

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.02

Q1'24

Missed

by $0.06

The last earnings report on March 28 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 47.41K shares outstanding, the current market capitalization sits at 109.05M.

View a ticker or compare two or three

Compare

GNLX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GNLX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2625 Townsgate Road

Phone

+1 805 267-9889

Employees

Web

https://www.genelux.com